SCHEMBL941268

SCHEMBL941268

Cc1cccc(Cl)c1S(=O)(=O)CNCc1nc2ccc(C(=O)O)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.47
APEX1 P27695 1/20 0.45
TOP2A P11388 1/20 0.44
HSP90AA1 P07900 1/20 0.44
ESR2 Q92731 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
HDAC6 Q9UBN7 2/20 0.42
HDAC1 Q13547 1/20 0.42
CYP1A2 P05177 1/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
CHEK2 O96017 3/20 0.40
TUBB4A P04350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL938644 0.82 NPSR1 (0.47) NPSR1APEX1TOP2AHSP90AA1ESR2
SCHEMBL938974 0.81 KDM5A (0.34) TDP1ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL941269 0.80 NPSR1 (0.47) NPSR1APEX1TOP2AHSP90AA1ESR2
SCHEMBL1017833 0.73 APEX1 (0.49) NPSR1APEX1TOP2AHSP90AA1ESR2
SCHEMBL938582 0.72 ALDH1A1 (0.42) TDP1ALDH1A1MAPK1SMN1; SMN2CYP1A2
SCHEMBL940188 0.72 CLCN2 (0.38) TDP1ALDH1A1MAPK1MEN1KMT2A
SCHEMBL4011603 0.71 DGAT1 (0.57) HSP90AA1ESR2TDP1HDAC6POLB
SCHEMBL11888774 0.70 GAA (0.41) POLBKMT2A
SCHEMBL5396738 0.68 NPSR1 (0.73) NPSR1APEX1TOP2AHSP90AA1ESR2
SCHEMBL3167498 0.67 DGAT1 (0.53) NPSR1HSP90AA1ESR2TDP1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 NPSR1 228/4885APEX1 3873/4885TOP2A 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.